RISK score for developing ventilator‐associated pneumonia in children: The RISVAP study

Objectives Ventilator‐associated pneumonia (VAP) is the second most common healthcare‐associated infection in children. The aim of this study was to determine the risk factors for VAP in children and to create a risk score for developing VAP (RISVAP score). Study design It was a prospective observational study, including children who required mechanical ventilation (MV), registered in the multicentre ENVIN‐HELICS database from 2014 to 2019. The regression coefficients of each independent risk factor for VAP were used to create the RISVAP score. Each factor scored 0 if it was absent, or, if it was present, an assigned value from 1 to 7, according to the regression coefficient. Results A total of 3798 patients were included, 97(2.5%) developing VAP. The independent risk factors for VAP were: female (odds ratio [OR]: 1.642, p = 0.024), MV > 4 days (OR: 26.79, p 7 days (OR: 11.74, p